Claus Henrik Nielsen

Claus Henrik Nielsen

Professor


  1. Published

    Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion

    Fassi, Daniel El , Nielsen, Claus Henrik, Hasselbalch, H. K. & Hegedüs, L., 1 Jul 2006, In: Thyroid. 16, 7, p. 709-10 2 p.

    Research output: Contribution to journalJournal articleResearch

  2. Published

    Evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves' disease

    Fassi, Daniel El , Clemmensen, O., Nielsen, Claus Henrik, Silkiss, R. Z. & Hegedüs, L., 1 Oct 2007, In: Journal of Clinical Endocrinology and Metabolism. 92, 10, p. 3762-3 2 p.

    Research output: Contribution to journalJournal articleResearch

  3. Published

    Biologiske behandlingsmuligheder ved Graves' oftalmopati

    Fassi, Daniel El , Nielsen, Claus Henrik & Hegedüs, L., 9 Jun 2008, In: Ugeskrift for Laeger. 170, 24, p. 2128-30 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study

    Fassi, Daniel El , Nielsen, Claus Henrik, Bonnema, S. J., Hasselbalch, H. K. & Hegedüs, L., 1 May 2007, In: Journal of Clinical Endocrinology and Metabolism. 92, 5, p. 1769-72 4 p.

    Research output: Contribution to journalJournal articleResearch

  5. Published

    The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option

    Fassi, Daniel El , Nielsen, Claus Henrik, Hasselbalch, H. K. & Hegedüs, L., 1 May 2006, In: European Journal of Endocrinology. 154, 5, p. 623-32 10 p.

    Research output: Contribution to journalJournal articleResearch

  6. Published

    Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease

    Fassi, Daniel El , Nielsen, Claus Henrik, Kjeldsen, J. B., Clemmensen, O. & Hegedüs, L., 1 May 2008, In: Gut. 57, 5, p. 714-5 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Rituximab (MabThera) til behandling af aktiv reumatoid artritis

    Fassi, Daniel El , Nielsen, Claus Henrik & Bendtzen, K., 20 Nov 2006, In: Ugeskrift for Laeger. 168, 47, p. 4079-81 3 p.

    Research output: Contribution to journalJournal articleResearch

  8. Published

    Single nucleotide polymorphisms in genes encoding toll-like receptors 7, 8 and 9 in Danish patients with systemic lupus erythematosus

    Enevold, Christian, Nielsen, Claus Henrik, Jacobsen, R. S., Hermansen, M. F., Molbo, Drude, Avlund, K., Bendtzen, K. & Jacobsen, Søren, 2014, In: Molecular Biology Reports. 41, 9, p. 5755-5763 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Genetic polymorphisms of dsRNA ligating pattern recognition receptors TLR3, MDA5, and RIG-I. Association with systemic lupus erythematosus and clinical phenotypes

    Enevold, Christian, Kjaer, L., Nielsen, Claus Henrik, Voss, A., Jacobsen, R. S., Hermansen, M. F., Redder, L., Oturai, A. B., Jensen, P. E., Bendtzen, K. & Jacobsen, Søren, 2014, In: Rheumatology International. 34, 10, p. 1401-1408 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. E-pub ahead of print
Previous 12 3 4 5 6 7 8 9 ...16 Next

ID: 927479